A laboratory-based study on patients with Parkinson's disease and seborrheic dermatitis: The presence and density of Malassezia yeasts, their different species and enzymes production

BMC Dermatology

Volumn 14, Issue , 2014, Pages

  Arsic Arsenijevic, Valentina S ^a   Milobratovic, Danica ^b   Barac, Aleksandra M ^a   Vekic, Berislav ^c   Marinkovic, Jelena ^a   Kostic, Vladimir S ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Alfa University   (Serbia)

^d Institute of Neurology Clinical Centre of Serbia   (Yugoslavia)

Author keywords

Colony forming units; Enzymes; Malassezia species; Parkinson's disease; Seborrheic dermatitis

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALPHA GLUCOSIDASE; ALPHA GLUCURONIDASE; ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA GLUCOSIDASE; BETA GLUCURONIDASE; ESTERASE; PHOSPHATASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; ERYTHEMA; FEMALE; FUNGUS CULTURE; HUMAN; IN VITRO STUDY; INCIDENCE; MAJOR CLINICAL STUDY; MALASSEZI GLOBOSA; MALASSEZIA; MALASSEZIA FURFUR; MALASSEZIA OBTUSA; MALASSEZIA SLOFFIAE; MALASSEZIA SYMPODIALIS; MALE; PARKINSON DISEASE; PROSPECTIVE STUDY; PUSTULE; SEBORRHEIC DERMATITIS; SEBUM SECRETION; SPECIES DIFFERENCE; FUNGAL DETECTION; MALASSEZIA GLOBOSA; NONHUMAN;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; FEMALE; HUMANS; LIPASE; MALASSEZIA; MALE; MIDDLE AGED; PARKINSON DISEASE; PHOSPHORIC MONOESTER HYDROLASES; PROSPECTIVE STUDIES; SKIN; YOUNG ADULT;

EID: 84899152119     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-14-5     Document Type: Article

References (30)

1. Yao SC, Hart AD, Terzella MJ. An evidence-based osteopathic approach to Parkinson disease. Osteopath Fam Physician 2013, 5:96-101.
2. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5:525-535. 10.1016/S1474-4422(06)70471-9, 16713924.
3. Kostić VS. Treatment of young-onset Parkinson's disease: role of dopamine receptor agonists. Parkinsonism Relat Disord 2009, 15:71-75. 10.1016/j.parkreldis.2008.01.020, 18395484.
4. Shuster S, Thody AJ, Goolamali SK, Burton JL, Plummer N, Bates D. Melanocyte-stimulating hormone and parkinsonism. Lancet 1973, 3:463-464.
5. Binder RL, Jonelis FJ. Seborrheic dermatitis in neuroleptic induced Parkinsonism. Arch Dermatol 1983, 119:473-475. 10.1001/archderm.1983.01650300027010, 6134496.
6. Naldi L, Rebora A. Clinical practice: seborrheic dermatitis. N Engl J Med 2009, 360:387-396. 10.1056/NEJMcp0806464, 19164189.
7. Marino CT, McDonald E, Romano JF. Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis 1991, 50:217-218.
8. Braak H, del Tredici K. Non-dopaminergic pathology in Parkinson's disease. The Non-Motor and Non-Dopaminergic Features of Parkinson's Disease 2011, 40-41. Oxford: Blackwell Publishing Ltd, Olanow CW, Stocchi F, Lang AE.
9. Mastrolonardo M. Seborrheic dermatitis, increased sebum excretion and Parkinson's disease: a survey of (im)possible links. Med Hypotheses 2003, 60:907-911. 10.1016/S0306-9877(03)00094-X, 12699724.
10. Ashbee HR, Evans EGV. Immunology of disease associated with Malassezia species. Clin Microbiol Rev 2002, 15:21-57. 10.1128/CMR.15.1.21-57.2002, 118058, 11781265.
11. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012, 25:106-141. 10.1128/CMR.00021-11, 3255962, 22232373.
12. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004, 51:785-798. 10.1016/j.jaad.2003.12.034, 15523360.
13. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001, 39:243-251. 10.1080/mmy.39.3.243.251, 11446527.
14. Pechère M, Krischer J, Remondat C, Bertrand C, Trellu L, Saurat JH. Malassezia spp. carriage in patients with seborrheic dermatitis. J Dermatol 1999, 26:558-561.
15. Koca R, Altinyazar HC, Esturk E. Is topical metronidazole effective in seborrheic dermatitis? A double blind study. Int J Dermatol 2003, 42:632-635. 10.1046/j.1365-4362.2003.01981.x, 12890109.
16. Pechère M, Remondat C, Bertrand C, Didierjean L, Saurat JH. A simple quantitative culture of Malassezia spp. in HIV-positive persons. Dermatology 1995, 191:348-349. 10.1159/000246598, 8573942.
17. Guillot J, Guého E, Lesourd M, Midgley G, Chevrier G, Dupont B. Identification ofMalasseziaspecies. J Mycol Med 1996, 6:103-110.
18. Aubin F, Blanc D, Guinchard C, Agache P. Absence of minocycline in sebum?. J Dermatol 1989, 16:369-373.
19. Villares JC, Carlini EA. Sebum secretion in idiopathic Parkinson's disease: effect of anticholinergic and dopaminergic drugs. Acta Neurol Scand 1989, 80:57-63. 10.1111/j.1600-0404.1989.tb03843.x, 2571233.
20. Gupta AK, Kohli Y. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med Mycol 2004, 42:35-42. 10.1080/13693780310001610056, 14982112.
21. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson's disease than women?. J Neurol Neurosurg Psychiatry 2004, 75:637-639. 10.1136/jnnp.2003.020982, 1739032, 15026515.
22. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the " common" neurologic disorders?. Neurology 2007, 68:326-337. 10.1212/01.wnl.0000252807.38124.a3, 17261678.
23. Martignoni E, Godi L, Pacchetti C, Berardesca E, Vignoli GP, Albani G, Mancini F, Nappi G. Is seborrhea a sign of autonomic impairment in Parkinson's disease?. J Neural Transm 1997, 104:1295-1304. 10.1007/BF01294730, 9503275.
24. Rincon S, Celis A, Sopo L, Motta A, Cepero de Garcia MC. Malassezia yeast species isolated from patients with dermatologic lesions. Biomedica 2005, 25:189-195.
25. Milani M, di Molfetta SA, Gramazio R, Fiorella C, Frisario C, Fuzio E, Marzocca V, Zurilli M, di Turi G, Felice G. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin 2003, 19:342-345. 10.1185/030079903125001875, 12841928.
26. Bolognia JL. Dermatology. Dermatology: 3e Expert Consult Premium Edition 2012, 75-77. Spain: Elsevier, Bolognia JL, Jorizzo JL, Schaffer JV.
27. Lee YW, Lee SY, Jung WH. Evaluation of expression of Lipases and Phospholipases of Malassezia in Patient with Seborrheic Dermatitis. Ann Dermatol 2013, 25:310-314. 10.5021/ad.2013.25.3.310, 3756195, 24003273.
28. Juntachai W, Oura T, Kajiwara S. Purification and characterization of a secretory lipolytic enzyme, MgLIP2, from Malassezia globosa. Microbiology 2011, 157:3492-3499. 10.1099/mic.0.054528-0, 22016565.
29. Juntachai W, Oura T, Murayama SY, Kajiwara S. The lipolytic enzymes activities of Malassezia species. Med Mycology 2009, 47:477-484.
30. de Angelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids and individual sensitivity. J Investig Dermatol Symp Proc 2005, 10:295-297. 10.1111/j.1087-0024.2005.10119.x, 16382685.